Results 81 to 90 of about 30,626 (259)
MicrobiologyOpen, Volume 14, Issue 6, December 2025.Treatment for chronic to invasive pulmonary aspergillosis typically involves azole antifungal drugs, although studies have shown varying minimum inhibitory concentrations (MIC) for these medications, with a growing concern over voriconazole resistance.
Aishwarya Nikhil +8 more
wiley +1 more source
Global Epidemiology of Mucormycosis
Journal of Fungi, 2019 Mucormycosis is an angio-invasive fungal infection, associated with high morbidity and mortality. A change in the epidemiology of mucormycosis has been observed in recent years with the rise in incidence, new causative agents and susceptible population ...
Hariprasath Prakash +1 more
doaj +1 more source
Proven invasive pulmonary mucormycosis successfully treated with amphotericin B and surgery in patient with acute myeloblastic leukemia: a case report [PDF]
, 2013 INTRODUCTION: Invasive mucormycosis (zygomycosis) is the third most frequent fungal infection in patients with hematologic malignancies. It often results in a fatal outcome mainly due to the difficulty of early diagnosis and its resistance to ...
Aleksandra Barac +6 more
core +1 more source
CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 12, Page 2198-2209, December 2025.ABSTRACT Isavuconazole is a broad‐spectrum triazole approved for the treatment of invasive aspergillosis or mucormycosis in adults and children aged ≥ 1 year. Current prescribing information lacks guidance regarding the co‐administration of isavuconazole with anticancer drugs–limited by the availability of clinical drug–drug interaction (DDI) data in ...
Theunis C. Goosen +6 more
wiley +1 more source
Medical Mycology Case Reports, 2017 Mucormycosis is a life threatening infection caused by fungi in the order Mucorales. Mucormycosis can affect any organ system with rhino-orbital-cerebral and pulmonary infections being the most predominant infection types.
Anthony Anderson +5 more
doaj +1 more source
Rhinocerebral zygomycosis in Pakistan: clinical spectrum, management, and outcome [PDF]
, 2011 OBJECTIVE: To study the disease spectrum and salient management features of 36 patients with histopathologically-confirmed rhinocerebral zygomycosis seen at our academic center over a 16-year period.
Ikram, Mubasher +5 more
core +1 more source
Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil [PDF]
, 2013 Invasive fungal disease (IFD) shows distinct regional incidence patterns and epidemiological features depending on the geographic region. We conducted a prospective survey in eight centres in Brazil from May 2007 to July 2009.
Bergamasco, M. D. +19 more
core +2 more sources
Surgical Debridement in Patients of Rhinocerebral Mucormycosis (RCM) Post COVID-19: A Prospective Study [PDF]
, 2022 Choudhary Shubham, C K Kiran Kumar
openalex +1 more source
Invasive Mucormycosis in Patients with Hemoblastosis in St.-Petersburg
Антибиотики и Химиотерапия, 2020 Thirty four patients with mucormycosis in 10 hospitals of St. Petersburg were observed in 2004-2013. The most frequent underlying diseases of mucormycosis were acute leukoses (64%). In 100% of the patients mucormycosis developed as a nosocomial infection.
S. N. Khostelidi +13 more
doaj
Rhizopus necrotizing fasciitis of caesarean wound: A rare life threatening condition [PDF]
, 2009 Mucormycosis is a rare cause of necrotizing fasciitis in immunocompromised patients. We report a young female, who developed rhizopus necrotizing fasciitis of caesarean wound.
Alvi, Abdul Rehman, Shamsi, Ghina
core +1 more source